2013 USCACA Annual Meeting at AACR

You are cordially Invitated to 2013 USCACA Annual Meeting
US Chinese Anti-Cancer Association Annual Meeting at AACR 2013

6:30 - 9:00 pm
April 7, 2013
Washington Plaza Hotel
10 Thomas Circle NW, Washington DC

Dear Colleagues,
On behalf of the organizing committee, we would like to cordially invite you to attend the US Chinese Anti-Cancer Association (USCACA) Annual Meeting at AACR 2013 at 6:30 - 9:00pm, April 7, 2013.

The meeting will highlight collaboration among USCACA, Chinese Anti-Cancer Association (CACA), Chinese Society of Clinical Oncology (CSCO), State Food and Drug Administration of China (SFDA), National Foundation of Cancer Research (NFCR), Tyler Institute for Genomic Medicine (TIGM), and Xinxiang Medical University, China, and major Chinese Pharmaceutical companies, will also update recent successes and explore opportunities to further foster translational research and facilitating oncology translational research and early clinical development. Your presence and presentation will undoubted enhance its scientific value and influence.

Please see below for RSVP information.

Sincerely yours,

Wei Zhang, PhD Li Yan, MD, PhD
President Managing Director

USCACA Annual Meeting Agenda

6:30 - 6:35
Introduction and Welcome - Dr. Roger Luo, USCACA Executive Committee, Annual Meeting Chair

6:35 - 6:45
USCACA Presidential Address - Dr. Wei Zhang, President, Dr. Shiyuan Cheng, President Elect, USCACA

6:45 - 6:50
Remark on CACA-USCACA Collaboration - Dr. Xishan Hao, Council Chairman of CACA

6:50 - 6:55
USCACA-NFCR (National Foundation of Cancer Research) Scholarship

6:55 - 7:30
USCACA and Tyler Institute for Genomic Medicine (TIGM) Award to Xinxiang
Medical University for Translational Research for Esophageal Cancer Prevention and Treatment

7:30-8:10
Panel Discussion: Application of Translational Research in Oncology R&D and its
Impact on Early Development in China - Dr. Michael Shi, Executive Committee, USCACA

- Dr. Chris Takimoto, Vice President, Head of Oncology TM & ED, Janssen Pharmaceutical Companies
- Dr. Nic Dracopoli, Vice President, Head of Oncology Biomarker, Janssen Pharmaceutical Companies
- Dr. Susan Pitman Lowenthal, Vice President of Medical Affairs of Oncology, Pfizer
- Dr. Zhiqing Yuan, Vice President for Research, Xinxiang Medical University
- Dr. Ying Wang, General Secretary of Chinese Anti-Cancer Association
- Dr. Helen Chen, National Cancer Institute's new Center for Global Health

8:10 - 8:15
Closing remarks - Dr. Wei Zhang, President, USCACA

8:15 - 9:00
Networking Time
RSVP Info
Seats are limited. Please kindly RSVP before Friday, March 29th to: 2013conference@uscaca.org with the following information,

Your name & title:
Affiliation:
E-mail:

We look forward to hearing your confirmation.

US Chinese Anti-Cancer Association
www.uscaca.org